About LSI Epsilon

Interest in investing in startups has grown in recent years. However, it is complex to analyze the deal flow, spread the risk and help the companies. Therefore, 23 experienced entrepreneurs are now joining forces to form LSI Epsilon, which will invest smart capital in early-stage companies. The company will invest in around ten early-stage Life Science, Healthtech, and Medtech companies in the Nordic region over the coming year and help them take the next step. The initiative is led by the entrepreneurs Ann-Charlotte Beckman, Magnus Klaesson and Kristofer Klerfalk.

LSI Epsilon  will invest SEK 17 million in Nordic life science companies during 2024/2025.